Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-22-000335
Filing Date
2022-01-05
Accepted
2022-01-05 17:00:31
Documents
1
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-54972.html 4  
1 PRIMARY DOCUMENT marketforms-54972.xml 4 3300
  Complete submission text file 0001214659-22-000335.txt   4748
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Issuer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address
Lehr Paul T (Reporting) CIK: 0001845674 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40060 | Film No.: 22512033